Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-040302 versus bone marrow aspirate or steroids for solitary bone cysts in children and young adults
2006-001294-18Phase 2Completed
- Sponsor
- Kuros Biosciences
- Start
- Jun 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of I-040302 in Simple Bone Cyst (SBC) (5 arms), sponsored by Kuros Biosciences. Primary endpoint: Cyst resolution at 6 months. Started Jun 2007; status: completed.
02
Drugs
I-040302
03
Conditions
Simple Bone Cyst (SBC)
Beyond the preview
Go deeper on 2006-001294-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001294-18.